Rallybio

(NASDAQ) RLYB

Current Price$14.11

Market Cap$49.78M

Since IPO (2021)-92%

5 YearN/A

1 Year+457%

1 Month+68%

Rallybio Financials at a Glance

Market Cap

$49.78M

Revenue (TTM)

$858.00K

Net Income (TTM)

$8.98M

EPS (TTM)

$-1.68

P/E Ratio

-5.60

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$14.11

Volume

10,663,604.592

Open

$14.02

Price

$14.11

Volume

10,663,604.592

Open

$14.02

Previous Close

$14.12

Daily Range

$13.24 - $14.60

52-Week Range

$2.16 - $14.60

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$14.11

Volume

10,663,604.592

Open

$14.02

Previous Close

$14.12

Daily Range

$13.24 - $14.60

52-Week Range

$2.16 - $14.60

RLYB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rallybio

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Stephen Uden, MD

Website

www.rallybio.com

Headquarters

New Haven, CT 06510, US

RLYB Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-39%

Net Income Margin

-10%

Return on Equity

-15%

Return on Capital

-57%

Return on Assets

-14%

Earnings Yield

-17.86%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$49.78M

Shares Outstanding

5.29M

Volume

10.66M

Avg. Volume

146.92K

Financials (TTM)

Gross Profit

$766.00K

Operating Income

$28.06M

EBITDA

$27.97M

Operating Cash Flow

$29.81M

Capital Expenditure

$0.00

Free Cash Flow

$29.81M

Cash & ST Invst.

$54.74M

Total Debt

$176.00K

Rallybio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$222.00K

+484.2%

Gross Profit

$219.00K

+2637.5%

Gross Margin

98.65%

N/A

Market Cap

$49.78M

N/A

Market Cap/Employee

$3.32M

N/A

Employees

N/A

Net Income

$5.85M

+47.0%

EBITDA

$6.41M

+44.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$54.56M

-16.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$82.00K

N/A

Short Term Debt

$94.00K

-39.0%

Return on Assets

-14.42%

N/A

Return on Invested Capital

-56.97%

N/A

Free Cash Flow

$4.68M

+52.6%

Operating Cash Flow

$4.68M

+52.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

QTTBQ32 Bio Inc.

QTTBQ32 Bio Inc.$5.04+0.00%

BOLDBoundless Bio, Inc.

BOLDBoundless Bio, Inc.$1.57+0.00%

IBIOiBio, Inc.

IBIOiBio, Inc.$1.58-0.63%

XCURExicure, Inc.

XCURExicure, Inc.$3.25+0.31%

TAOXTAO Synergies Inc.

TAOXTAO Synergies Inc.$5.38+0.94%

CVKDCadrenal Therapeutics, Inc. Common Stock

CVKDCadrenal Therapeutics, Inc. Common Stock$6.61+4.09%

INTSIntensity Therapeutics, Inc.

INTSIntensity Therapeutics, Inc.$5.20+0.19%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.14-0.01%

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.84+2.39%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.34+0.58%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

PLTRPalantir Technologies

PLTRPalantir Technologies$146.03+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.69-0.00%

SOFISoFi Technologies

SOFISoFi Technologies$16.20-0.01%

Questions About RLYB

What is the current price of Rallybio?

Rallybio is trading at $14.12 per share.

What is the 52-week range for Rallybio?

Over the past 52 weeks, Rallybio has traded between $2.16 and $14.60.

How much debt does Rallybio have?

As of the most recent reporting period, Rallybio reported total debt of $176,000.

How much cash does Rallybio have on hand?

Rallybio reported $31.37M in cash and cash equivalents in its most recent financial results.

What is Rallybio’s dividend yield?

Rallybio does not currently have a dividend yield.

Rallybio

Rallybio Financials at a Glance

RLYB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Rallybio

RLYB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Rallybio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RLYB

What is the current price of Rallybio?

What is the 52-week range for Rallybio?

How much debt does Rallybio have?

How much cash does Rallybio have on hand?

What is Rallybio’s dividend yield?

Premium Investing Services